Market Analysis
The global biologics market is anticipated to touch USD 285,520.4
million at a 6.95% CAGR between 2018-2023, states the new Market
Research Future (MRFR) report. Biologics, simply put, are made from
materials that come from various living organisms such as animals,
humans, and microorganisms, namely yeast or bacteria. Usually,
biological products are manufactured, utilizing biotechnology methods or
other advanced technologies. They are widely used for providing
effective treatment for several complex diseases, including Crohn’s
disease, psoriasis, and rheumatoid arthritis, which have limited options
for treatment. Biologics is transforming the manner in which physicians
treat common conditions that have plagued people for years. They have
many potential benefits as; theoretically, they can be customized for
hitting particular gene targets in the body
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1339
Numerous factors are propelling the Biologics Market Growth.
Such factors, as per the new Market Research Future report, include
unremitting research & development activities, rising regulatory
convergence, increasing government initiatives in the healthcare sector,
growing demand as well as higher acceptability of innovative therapies,
and the emergence of orphan drugs and personalized medicines.
Additional factors propelling the growth of the biologics market include
improvement in the healthcare infrastructure, rapid urbanization,
increasing awareness about the efficacy and performance of biologics,
and increasing prevalence of different chronic diseases.
On the contrary, stringent government regulations, higher
supervision, the rise of biosimilars, pricing pressures coming from
regulators, difficulty to manufacture biologics, and side effects such
as breathing problems, chest pain, change in blood pressure, and
gastrointestinal complications are factors that may hamper the biologics
market growth during the forecast period.
Market Segmentation
The Market Research Future report offers a complete segmental
analysis of the biologics market based on manufacturing, disease
indication, and product.
Based on product, the global biologics market is segmented into gene
therapy, growth factors, vaccines, interleukins, monoclonal antibody,
and others. Of these, the monoclonal antibody segment will have the
largest share in the market during the forecast period for its
increasing use for enhancing the body’s immunity system.
Based on disease indication, the biologics market is segmented into
diabetes, cancer, psoriasis/psoriatic arthritis, rheumatoid arthritis,
and others. Of these, the cancer segment dominated the market in 2018,
but rheumatoid arthritis is predicted to dominate the biologics market
over the forecast period for the rapid approval of different drugs by
the regulatory agencies.
Based on manufacturing, the biologics market is segmented into
outsourced and in-house. Of these, the outsourced segment will have the
maximum share in the market during the forecast period for the presence
of several pharmaceutical companies, especially in developing countries.
Regional Analysis
By region, the biologics market report covers the latest trends and
growth opportunities across the Americas, the Asia Pacific, Europe, and
the Middle East and Africa. Of these, the Americas will dominate the
market during the forecast period. Various factors are propelling the
growth of the biologics market in the region, such as investments in new
facilities for producing drugs for clinical trials, strong economic
growth of Canada and the US, and rapid adoption of manufacturing
technologies. It is predicted to touch USD 129,652.7 million at a 4.31%
CAGR.
The biologics market in the APAC region will grow at the fastest pace
during the forecast period. Various factors are propelling the growth
of the biologics market in the region, such as the changing healthcare
sector, increasing geriatric populace, and the presence of different
contract manufacturing organizations (CMOs) in the region. India is a
major contributor in this region for its massive strides in biologics
manufacturing.
Key Players
Notable players profiled in the biologics market report include
GlaxoSmithKline Plc (UK), Eli Lilly and Company (US), Bayer AG
(Germany), Sanofi (France), F. Hoffman-La Roche AG (Switzerland),
Novartis AG (Switzerland), Amgen (US), Pfizer Inc. (US), AstraZeneca
(UK), and AbbVie, Inc. (US). Key players have incorporated specific
strategies to increase their market share, such as acquisitions,
expansions, and new product launches.
Industry News
December 2019: Researchers at the Shenzhen Institutes of Advanced
Technology, China, and Duke University, US, have created a platform that
will make the biologics production process simpler.
1 Report Prologue
2 Market Introduction
2.1 Introduction 15
2.2 Scope Of The Study 15
2.3 Assumptions & Limitations 15
3 Research Methodology
3.1 Research Process 18
3.2 Primary Research 19
3.3 Secondary Research 20
3.4 Market Size Estimation 21
3.5 Forecast Model 21
4 Market Dynamics
4.1 Introduction 23
4.2 Drivers 23
4.2.1 Increasing Healthcare Expenditure 23
4.2.2 Advancements In Biologics 24
4.2.3 Rising Prevalence Of Chronic And Acute Diseases 24
4.3 Restraints 24
4.3.1 Emergence Of Biosimilars 24
4.3.2 Adverse Effects Of Biologic Drugs 24
4.4 Opportunities 25
4.4.1 Strong Pipeline For Biologic Drugs 25
5 Market Factor Analysis
5.1 Value/Supply Chain Analysis 27
5.1.1 Research & Development 27
5.1.2 Raw Material 27
5.1.3 Manufacturer 27
5.1.4 Distributor 28
5.1.5 Customer 28
5.1.6 Consumer 28
5.2 Porter’s Five Force Analysis 29
5.2.1 Threat From A New Entrant 30
5.2.2 Bargaining Power Of Buyer 30
5.2.3 Bargaining Power Of Supplier 30
5.2.4 Threat From Substitute 31
5.2.5 Rivalry 31
5.3 Investment Opportunity Analysis 32
5.3.1 Investment Risks 32
5.3.2 Market Outlook 32
5.4 Pricing Analysis 32
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/biologics-market-1339
Get Our More Trending Research Report Here:-
Amyotrophic Lateral Sclerosis Market
Compression Therapy Market
Eclinical Solutions Market
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel
the complexity of various industries through our Cooked Research Report
(CRR), Half- Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting
Services. MRFR team have supreme objective to provide the optimum
quality market research and intelligence services to our clients. Our
market research studies by Components, Application, Logistics and market
players for global, regional, and country level market segments, enable
our clients to see more, know more, and do more, which help to answer
all their most important questions. In order to stay updated with
technology and work process of the industry, MRFR often plans &
conducts meet with the industry experts and industrial visits for its
research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
https://marketreports4u.blogspot.com/
Comments
Post a Comment